Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway.
[allergic bronchopulmonary aspergillosis]
Systemic
administration
of
mesenchymal
stromal
cells
(
MSCs
)
suppresses
airway
inflammation
and
methacholine-induced
airway
hyper-responsiveness
(
AHR
)
in
mouse
models
of
T
helper
cell
(
Th
)
type
2
-
mediated
eosinophilic
allergic
airway
inflammation
(
AAI
)
;
however
,
the
efficacy
of
MSCs
in
mouse
models
of
severe
Th
17
-
mediated
neutrophilic
AAI
has
not
yet
been
demonstrated
.
We
assessed
MSC
effects
in
a
mouse
model
of
mixed
Th
2
/
Th
17
AAI
produced
by
mucosal
exposure
to
Aspergillus
fumigatus
hyphal
extract
(
AHE
)
.
Following
sensitization
produced
by
oropharyngeal
AHE
administration
,
systemic
(
tail
vein
)
administration
of
syngeneic
MSCs
on
the
first
day
of
challenge
significantly
reduced
acute
AHR
predominantly
through
reduction
of
Th
17
-
mediated
airway
inflammation
.
In
parallel
experiments
,
MSCs
also
mitigated
AHR
when
administered
during
recurrent
challenge
10
weeks
after
initial
sensitization
and
challenge
through
reduction
in
systemic
Th
17
-
mediated
inflammation
.
Investigation
into
potential
mechanistic
actions
of
MSCs
in
this
model
demonstrated
that
although
T
regulatory
cells
were
increased
in
all
AHE-treated
mice
,
MSC
administration
did
not
alter
T
regulatory
cell
numbers
in
either
the
acute
or
recurrent
model
.
Differential
induction
of
interleukin-
17
a
secretion
was
observed
in
ex
vivo
restimulation
of
mediastinal
lymph
node
mixed
-cell
cytokine
analyses
.
Although
the
mechanisms
by
which
MSCs
act
to
decrease
inflammation
and
AHR
in
this
model
are
not
yet
fully
elucidated
,
decrease
in
Th
17
-
mediated
airway
inflammation
appears
to
play
a
significant
role
.
These
results
provide
a
basis
for
further
investigations
of
MSC
administration
as
a
potential
therapeutic
approach
for
severe
refractory
neutrophilic
asthma
.
Diseases
Validation
Diseases presenting
"first day"
symptom
allergic bronchopulmonary aspergillosis
harlequin ichthyosis
homocystinuria without methylmalonic aciduria
lamellar ichthyosis
monosomy 21
pyruvate dehydrogenase deficiency
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom